SCR-LIP-000506 · Claim · machine-readable JSON →

This narrative review on lipedema pathophysiology and management describes clinical classification systems (Amato distribution types I-V, morphological stages I-IV), imaging diagnostics, and therapeutic strategies including WAL/PAL/TAL liposuction, but does not present a historical timeline of milestones in the condition's description or surgical treatment.

This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026Lipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · contextual

Evidence (1)

Context (PECO)

Populationwomen with lipedema (Brazilian context)
Conditionlipedema
Exposureconservative, pharmacological, and surgical (liposuction) management
Outcomediagnostic and therapeutic framework
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log